Oral Chaperone Therapy: A Convenient Treatment for Fabry Disease
Oral chaperone therapy is a treatment option for individuals with Fabry disease. It involves the use of a small molecule that helps repair the defective alpha-GAL enzymes, allowing them to effectively break down the fatty substance and prevent further damage. Unlike other treatment methods, oral chaperone therapy comes in the form of a pill, making it highly convenient for patients.
It’s important to note that oral chaperone therapy is only effective for specific mutations and patients. However, for those who are eligible, this treatment offers a convenient and accessible way to manage Fabry disease and minimize its associated complications.
ACE Inhibitors for Managing Fabry Disease
Fabry disease patients often find relief through the use of ACE inhibitors, a commonly prescribed treatment. By reducing the presence of protein in the urine, these medications can effectively prolong kidney function, potentially eliminating the need for dialysis or a kidney transplant. Notably, in the event that a person with Fabry disease undergoes a kidney transplant, the transplanted organ will remain unaffected by the disease, restoring kidney function to a normal state.